Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

  1. Sara G Dosil
  2. Sheila Lopez-Cobo
  3. Ana Rodriguez-Galan
  4. Irene Fernandez-Delgado
  5. Marta Ramirez-Huesca
  6. Paula Milan-Rois
  7. Milagros Castellanos
  8. Alvaro Somoza
  9. Manuel J Gómez
  10. Hugh T Reyburn
  11. Mar Vales-Gomez
  12. Francisco Sánchez Madrid  Is a corresponding author
  13. Lola Fernandez-Messina  Is a corresponding author
  1. Universidad Autónoma de Madrid, Spain
  2. INSERM U932, Institut Curie, PSL Research University, France
  3. National Center for Cardiovascular Research, Spain
  4. Unidad Asociada al Centro Nacional de Biotecnología, Spain
  5. Spanish National Research Council, Spain

Abstract

Natural killer (NK) cells recognise and kill target cells undergoing different types of stress. NK cells are also capable of modulating immune responses. In particular, they regulate T cell functions. Small RNA next-generation sequencing of resting and activated human NK cells and their secreted EVs led to the identification of a specific repertoire of NK-EV-associated microRNAs and their post-transcriptional modifications signature. Several microRNAs of NK-EVs, namely miR-10b-5p, miR-92a-3p and miR-155-5p, specifically target molecules involved in Th1 responses. NK-EVs promote the downregulation of GATA3 mRNA in CD4+ T cells and subsequent TBX21 de-repression that leads to Th1 polarization and IFN-γ and IL-2 production. NK-EVs also have an effect on monocyte and moDCs function, driving their activation and increased presentation and co-stimulatory functions. Nanoparticle-delivered NK-EV microRNAs partially recapitulate NK-EV effects in mice. Our results provide new insights on the immunomodulatory roles of NK-EVs that may help to improve their use as immunotherapeutic tools.

Data availability

Sequencing data have been deposited in the Gene Expression Omnibus and are available to readers under record GSE185171. EV isolation procedures are available at EV‐TRACK knowledgebase (EV‐TRACK ID: EV210234.

The following data sets were generated

Article and author information

Author details

  1. Sara G Dosil

    Servicio de Inmunología, Universidad Autónoma de Madrid, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  2. Sheila Lopez-Cobo

    INSERM U932, Institut Curie, PSL Research University, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Ana Rodriguez-Galan

    Servicio de Inmunología, Universidad Autónoma de Madrid, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6209-782X
  4. Irene Fernandez-Delgado

    Servicio de Inmunología, Universidad Autónoma de Madrid, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  5. Marta Ramirez-Huesca

    Vascular Pathophysiology Area, National Center for Cardiovascular Research, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  6. Paula Milan-Rois

    Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia) & Nanobiotecnología (IMDEA-Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7043-2920
  7. Milagros Castellanos

    Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia) & Nanobiotecnología (IMDEA-Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  8. Alvaro Somoza

    Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia) & Nanobiotecnología (IMDEA-Nanociencia), Unidad Asociada al Centro Nacional de Biotecnología, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  9. Manuel J Gómez

    Vascular Pathophysiology Area, National Center for Cardiovascular Research, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  10. Hugh T Reyburn

    Department of Immunology and Oncology, Spanish National Research Council, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  11. Mar Vales-Gomez

    Department of Immunology and Oncology, Spanish National Research Council, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  12. Francisco Sánchez Madrid

    Servicio de Inmunología, Universidad Autónoma de Madrid, Madrid, Spain
    For correspondence
    fsmadrid@salud.madrid.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5303-0762
  13. Lola Fernandez-Messina

    Servicio de Inmunología, Universidad Autónoma de Madrid, Madrid, Spain
    For correspondence
    lfernandezmessina@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2163-8746

Funding

Spanish National Plan for Scientific and Technical Research and Innovation (PD1-2020-120412RB-100)

  • Francisco Sánchez Madrid

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Shimon Sakaguchi, Osaka University, Japan

Ethics

Animal experimentation: All experimental methods and protocols were approved by the CNIC and the Comunidad Autónoma de Madrid and conformed to European Commission guidelines and regulations (PROEX-206.1/20)

Version history

  1. Received: December 13, 2021
  2. Preprint posted: January 7, 2022 (view preprint)
  3. Accepted: July 17, 2022
  4. Accepted Manuscript published: July 29, 2022 (version 1)
  5. Version of Record published: August 10, 2022 (version 2)

Copyright

© 2022, Dosil et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,888
    views
  • 483
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sara G Dosil
  2. Sheila Lopez-Cobo
  3. Ana Rodriguez-Galan
  4. Irene Fernandez-Delgado
  5. Marta Ramirez-Huesca
  6. Paula Milan-Rois
  7. Milagros Castellanos
  8. Alvaro Somoza
  9. Manuel J Gómez
  10. Hugh T Reyburn
  11. Mar Vales-Gomez
  12. Francisco Sánchez Madrid
  13. Lola Fernandez-Messina
(2022)
Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses
eLife 11:e76319.
https://doi.org/10.7554/eLife.76319

Share this article

https://doi.org/10.7554/eLife.76319

Further reading

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Mark S Lee, Peter J Tuohy ... Michael S Kuhns
    Research Advance

    CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al., 2022). Expressing mutants of these motifs together in T cell hybridomas increased CD4-LCK association but reduced CD3ζ, ZAP70, and PLCγ1 phosphorylation levels, as well as IL-2 production, in response to agonist pMHCII. Because these mutants preferentially localized CD4-LCK pairs to non-raft membrane fractions, one explanation for our results was that they impaired proximal signaling by sequestering LCK away from TCR-CD3. An alternative hypothesis is that the mutations directly impacted signaling because the motifs normally play an LCK-independent role in signaling. The goal of this study was to discriminate between these possibilities. Using T cell hybridomas, our results indicate that: intracellular CD4-LCK interactions are not necessary for pMHCII-specific signal initiation; the GGXXG and (C/F)CV+C motifs are key determinants of CD4-mediated pMHCII-specific signal amplification; the GGXXG and (C/F)CV+C motifs exert their functions independently of direct CD4-LCK association. These data provide a mechanistic explanation for why residues within these motifs are under purifying selection in jawed vertebrates. The results are also important to consider for biomimetic engineering of synthetic receptors.

    1. Genetics and Genomics
    2. Immunology and Inflammation
    Jean-David Larouche, Céline M Laumont ... Claude Perreault
    Research Article

    Transposable elements (TEs) are repetitive sequences representing ~45% of the human and mouse genomes and are highly expressed by medullary thymic epithelial cells (mTECs). In this study, we investigated the role of TEs on T-cell development in the thymus. We performed multiomic analyses of TEs in human and mouse thymic cells to elucidate their role in T-cell development. We report that TE expression in the human thymus is high and shows extensive age- and cell lineage-related variations. TE expression correlates with multiple transcription factors in all cell types of the human thymus. Two cell types express particularly broad TE repertoires: mTECs and plasmacytoid dendritic cells (pDCs). In mTECs, transcriptomic data suggest that TEs interact with transcription factors essential for mTEC development and function (e.g., PAX1 and REL), and immunopeptidomic data showed that TEs generate MHC-I-associated peptides implicated in thymocyte education. Notably, AIRE, FEZF2, and CHD4 regulate small yet non-redundant sets of TEs in murine mTECs. Human thymic pDCs homogenously express large numbers of TEs that likely form dsRNA, which can activate innate immune receptors, potentially explaining why thymic pDCs constitutively secrete IFN ɑ/β. This study highlights the diversity of interactions between TEs and the adaptive immune system. TEs are genetic parasites, and the two thymic cell types most affected by TEs (mTEcs and pDCs) are essential to establishing central T-cell tolerance. Therefore, we propose that orchestrating TE expression in thymic cells is critical to prevent autoimmunity in vertebrates.